Industry Seeks Clarification On Applicability Of Regs For Combo Products
This article was originally published in The Pink Sheet Daily
Executive Summary
Comments on FDA's combination products draft guidance ask for clarification of the regulatory requirements when the separate components are produced as a single entity or co-packaged. FDA views the dual applicability as manageable since there is "considerable overlap" between pharmaceutical cGMPs and device quality system regs.